By: IPP Bureau
Last updated : February 20, 2024 12:46 pm
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
IOL Chemicals and Pharmaceuticals Limited's product Metformin Hydrochloride has been approved by Center for Drug Evaluation (CDE) of National Medical Products Administration (NMPA), China. This will enable the Company to export Metformin Hydrochloride in China Market. Metformin Hydrochloride is an antidiabetic drug which is used to manage the high blood sugar levels in diabetes patients.
USFDA completes inspection at Auro Peptides Ltd's facility with zero observations
The manufacturing unit of Auro Peptides Ltd, the synthetic peptides API business arm of Aurobindo Pharma Ltd, situated at Indrakaran Village, Kandi Mandal, Sangareddy District, Telangana, was audited by the US FDA from 12th to 16th February 2024. The inspection was concluded with zero observations.